Crossmark

Double-blind, non-inferiority, randomized controlled trial of dexamethasone 4, 5 and 6 mg for preventing adverse neonatal and maternal outcomes in very preterm to late preterm pregnancies between 29 0 and 36 6 weeks of gestation: study protocol

Crossref DOI link: https://doi.org/10.1186/s12978-025-01965-8

Published Online: 2025-03-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chawanpaiboon, Saifon

Wutthigate, Punnanee

Anuwutnavin, Sanitra

Sutchritpongsa, Sureelak
Funding

Funding for this research was provided by:

Faculty of Medicine Siriraj Hospital, Mahidol University

Royal Thai College of Obstetrics and Gynaecology
License Information

Text and Data Mining valid from 2025-03-03

Version of Record valid from 2025-03-03
More Information

Article History

Received: 26 January 2025

Accepted: 4 February 2025

First Online: 3 March 2025

Declarations

:

: Ethics approval has been granted by the Faculty of Medicine Siriraj Hospital (Si 480/2019). All the authors have completed the International Committee of Medical Journal Editors’ Form for Uniform Disclosure of Potential Conflicts of Interest and declare that they have nothing to disclose. All procedures involving human participants will be conducted in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Written informed consent will be obtained from all study participants.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below